Epi CanaryEpi Canary
  • Home
  • Feed
  • Synthesis
  • Assessments
  • Scopes
  • Reliability
  • Sources
Epi Canary — Epidemic IntelligenceEvidence-led epidemic intelligence. Source-attributed evidence.
Arcede logoMade by Arcede

Public note

For situational awareness and research transparency. Not medical advice.

Novel Pathogen Detectionactive

BA.3.2 will show documented excess pediatric hospitalization burden vs adult rate in at least one national surveillance dataset by Sep 30 2026.

System-generated assessment. This assessment remains under review until the stated horizon or until sufficient evidence allows evaluation.

Substantial confidence

Confidence in this assessment
60%

Multiple lines of evidence are aligned, though the assessment remains provisional. Based on 0 linked evidence items and assessed against 180D.

Assessed through 180D·0 linked evidence items·Tracking since Apr 21, 2026

02

How this assessment will be evaluated

The criteria the system uses to determine whether this assessment is borne out by the stated horizon.

Automated

Method

Evidence Match

The condition the system checks for when evaluating this assessment.

Minimum source quality

T1Primary Institutional

Evidence must meet or exceed this credibility tier to count toward evaluation.

Required terms

hospitalizationsurveillancedocumentedpediatric

03

Evidence quality mix

Tracking since Apr 21, 2026.

▸Integrity referencesCryptographic hashes for verification

Registration

06

Scope synthesis

The current analyst narrative for this scope.

Open synthesis →

MERS-CoV camel-to-human case documented in Somalia; SARS-CoV-2 global activity elevated but consistent with seasonal norms; no novel sarbeco/merbeco emergence signal.

No age-stratified hospitalization data; BA.3.2 severity pattern unconfirmed

07

Evidence linked to this assessment

0 linked items.

No linked evidence is available for this assessment yet.

Integrity anchor

Brier 0.202

19 resolved novel pathogen detection predictions.